EP4061370A4 - Composition de granulés comprenant de la propivérine ou un sel pharmaceutiquement acceptable de celle-ci - Google Patents

Composition de granulés comprenant de la propivérine ou un sel pharmaceutiquement acceptable de celle-ci Download PDF

Info

Publication number
EP4061370A4
EP4061370A4 EP20889321.4A EP20889321A EP4061370A4 EP 4061370 A4 EP4061370 A4 EP 4061370A4 EP 20889321 A EP20889321 A EP 20889321A EP 4061370 A4 EP4061370 A4 EP 4061370A4
Authority
EP
European Patent Office
Prior art keywords
propiverine
granules
composition
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20889321.4A
Other languages
German (de)
English (en)
Other versions
EP4061370A1 (fr
Inventor
Fatih Sunel
Ediz Yildirim
Gulcin TOK
Bulent DEMIR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP4061370A1 publication Critical patent/EP4061370A1/fr
Publication of EP4061370A4 publication Critical patent/EP4061370A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP20889321.4A 2019-11-19 2020-10-27 Composition de granulés comprenant de la propivérine ou un sel pharmaceutiquement acceptable de celle-ci Pending EP4061370A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2019/18013A TR201918013A2 (tr) 2019-11-19 2019-11-19 Propi̇veri̇n veya propi̇veri̇ni̇n farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzunu i̇çeren pellet kompozi̇syonu
PCT/TR2020/050998 WO2021101481A1 (fr) 2019-11-19 2020-10-27 Composition de granulés comprenant de la propivérine ou un sel pharmaceutiquement acceptable de celle-ci

Publications (2)

Publication Number Publication Date
EP4061370A1 EP4061370A1 (fr) 2022-09-28
EP4061370A4 true EP4061370A4 (fr) 2023-08-02

Family

ID=75980701

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20889321.4A Pending EP4061370A4 (fr) 2019-11-19 2020-10-27 Composition de granulés comprenant de la propivérine ou un sel pharmaceutiquement acceptable de celle-ci

Country Status (4)

Country Link
EP (1) EP4061370A4 (fr)
CA (1) CA3162408C (fr)
TR (2) TR201918013A2 (fr)
WO (1) WO2021101481A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023080856A1 (fr) * 2021-11-03 2023-05-11 Santa Farma Ilac Sanayii A.S. Composition pharmaceutique de chlorhydrate de propivérine à enrobage entérique
WO2023128906A1 (fr) * 2021-12-30 2023-07-06 Santa Farma Ilac Sanayii A.S. Libération de compositions de propivérine dans des conditions gastriques

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090258066A1 (en) * 2008-04-15 2009-10-15 Gopi Venkatesh Compositions comprising weakly basic drugs and controlled-release dosage forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10149674A1 (de) * 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
ITMI20061024A1 (it) * 2006-05-25 2007-11-26 Eurand Pharmaceuticals Ltd Pellet a base di acido lipoico
CN102579404A (zh) 2012-01-17 2012-07-18 广州科的信医药技术有限公司 一种盐酸丙哌维林缓释胶囊及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090258066A1 (en) * 2008-04-15 2009-10-15 Gopi Venkatesh Compositions comprising weakly basic drugs and controlled-release dosage forms

Also Published As

Publication number Publication date
CA3162408C (fr) 2024-11-05
EP4061370A1 (fr) 2022-09-28
WO2021101481A1 (fr) 2021-05-27
TR202016210A2 (tr) 2021-06-21
TR201918013A2 (tr) 2021-06-21
CA3162408A1 (fr) 2021-05-27

Similar Documents

Publication Publication Date Title
EP3843714A4 (fr) Inhibiteurs de cd73
IL277006A (en) CD73 inhibitors
EP3871673A4 (fr) Nouveau composé d'indazole ou sel de celui-ci
IL304348A (en) cd73 inhibitors
EP3974441A4 (fr) Nouveau composé peptidique ou sel pharmaceutiquement acceptable de celui-ci
IL290561A (en) Alkynyl quinazoline compounds
PL4051688T3 (pl) Inhibitory cd73
EP3999517A4 (fr) Inhibiteurs de cd73
PL4055021T3 (pl) Heterocykliczne związki hamujące RIP1
EP4021896A4 (fr) Sel
EP3953057A4 (fr) Kit d'extension de colonne montante pour arroseur
EP3909584A4 (fr) Composé pyrimidine ou sel correspondant
EP3829551A4 (fr) Sel de malonate d'épinéphrine cristallin
GB201910290D0 (en) Herbicidal compounds
MA56001A (fr) Formes de sel cristallin d'un inhibiteur de kinase
EP3899249C0 (fr) Correction de l'angle de pas
MA53162A (fr) Sel de xinafoate d'un composé inhibiteur de jak
EP3938457A4 (fr) Composition d'enrobage thermoconductrice
ZA202108764B (en) Herbicidal composition
EP3650444A4 (fr) Sel et polymorphe de composé benzopyrimidinone, composition pharmaceutique et utilisation associée
EP3942593A4 (fr) Détermination d'élution de composé agnostique
EP3851438A4 (fr) Inhibiteur de btk, sel pharmaceutiquement acceptable, polymorphe et application de celui-ci
EP3790664A4 (fr) Gicleur d'incendie rotatif
EP3813812A4 (fr) Dosage d'acétaminophène
EP3834620C0 (fr) Composition de boisson lactée au café

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220517

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230703

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/22 20060101ALI20230627BHEP

Ipc: A61K 9/20 20060101ALI20230627BHEP

Ipc: A61K 9/16 20060101ALI20230627BHEP

Ipc: A61K 9/50 20060101ALI20230627BHEP

Ipc: A61K 47/38 20060101ALI20230627BHEP

Ipc: A61P 13/10 20060101ALI20230627BHEP

Ipc: A61P 13/00 20060101ALI20230627BHEP

Ipc: A61K 31/445 20060101AFI20230627BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240314

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET A.S.